Your browser doesn't support javascript.
loading
Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
Müller, Iris I; Müller, Karin A L; Karathanos, Athanasios; Schönleber, Heiko; Rath, Dominik; Vogel, Sebastian; Chatterjee, Madhumita; Schmid, Martina; Haas, Maximilian; Seizer, Peter; Langer, Harald; Schaeffeler, Elke; Schwab, Matthias; Gawaz, Meinrad; Geisler, Tobias.
Afiliação
  • Müller II; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Müller KA; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Karathanos A; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Schönleber H; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Rath D; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Vogel S; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Chatterjee M; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Schmid M; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Haas M; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Seizer P; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Langer H; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany.
  • Schaeffeler E; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Schwab M; Department of Clinical Pharmacology, University Hospital of Tübingen, Tübingen, Germany; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Gawaz M; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany. Electronic address: meinrad.gawaz@med.uni-tuebingen.de.
  • Geisler T; Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, University Hospital of Tübingen, Tübingen, Germany. Electronic address: tobias.geisler@med.uni-tuebingen.de.
Atherosclerosis ; 237(2): 426-32, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25463068
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fatores Inibidores da Migração de Macrófagos / Oxirredutases Intramoleculares / Peptídeos e Proteínas de Sinalização Intercelular / Síndrome Coronariana Aguda Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fatores Inibidores da Migração de Macrófagos / Oxirredutases Intramoleculares / Peptídeos e Proteínas de Sinalização Intercelular / Síndrome Coronariana Aguda Idioma: En Ano de publicação: 2014 Tipo de documento: Article